Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
Elizabeth A. Suarez(Brigham and Women's Hospital), Brian T. Bateman(American Pharmacists Association), Loreen Straub(Brigham and Women's Hospital), Mishka Terplan(Grand Rapids Community College), Krista F. Huybrechts(Brigham and Women's Hospital), Jonathan M. Davis(University of Alabama at Birmingham), Hilary S. Connery(American Pharmacists Association), Hendrée E. Jones(Johns Hopkins University), Helen Mogun(Brigham and Women's Hospital), Kathryn J. Gray(American Pharmacists Association), Barry M. Lester(Providence College), Sonia Hernández–Dı́az(Harvard University)
Cited by 150
Related Papers
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
|New England Journal of Medicine|2007|497
The Birth Weight "Paradox" Uncovered?
|American Journal of Epidemiology|2006|359
Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts
|Obstetrics and Gynecology|2018|322
The Maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report
|PEDIATRICS|2001|307
Racial and Ethnic Disparities in the Incidence of Severe Maternal Morbidity in the United States, 2012–2015
|Obstetrics and Gynecology|2018|296